Norway Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Norway Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new report provides granular analysis of the Norway diagnostic testing market, including volume and sales forecasts by test for the following market segments:

– Blood Banking
– Cancer
– Chemistry
– Coagulation
– Drugs of Abuse
– Endocrine
– Hematology and Flow Cytometry
– Immunoprotein
– Infectious Diseases
– Molecular Diagnostics
– TDM

Table of Contents

Market Overview

Blood Banking Market

Table 1: Blood Bank Test Volume and Reagent Sales Forecast by Test Category

Table 2: Blood Typing and Grouping Volume Forecast by Test

Table 3: Infectious Disease Screening Volume Forecast by Test

Table 4: Blood Typing and Grouping Reagent Market Forecast by Test

Table 5: Infectious Disease Screening Reagent Market Forecast by Test

Cancer Diagnostics Market

Table 6: Cancer Diagnostic Volume Forecast by Test

Table 7: Cancer Diagnostics Sales Forecast by Test

Clinical Chemistry and Immunodiagnostics Market

Table 8: Routine Chemistry Volume Forecast by Test

Table 9: Endocrine Function Volume Forecast by Test

Table 10: Tumor Markers and Special Chemistry Volume Forecast by Test

Table 11: Tumor Markers and Special Chemistry Volume Forecast by Test

Table 12: Immunoprotein Volume Forecast by Test

Table 13: TDM Volume Forecast by Test

Table 14: Drugs of Abuse Volume Forecast by Test

Table 15: Clinical Chemistry and Immunoassay Calibrator and Control Market
Forecast by Test Category

Table 16: Routine Chemistry Reagent Market Forecast by Test

Table 17: Endocrine Function Reagent Market Forecast by Test

Table 18: Tumor Markers and Special Chemistry Reagent Market Forecast by Test

Table 19: Immunoprotein Reagent Market Forecast by Test

Table 20: TDM Reagent Market Forecast by Test

Table 21: Drugs of Abuse Reagent Market Forecast by Test

Table 22: Clinical Chemistry and Immunoassay Instrument Market Forecast by
Analyzer Type

Coagulation Testing Market

Table 23: Coagulation Test Volume Forecast by Procedure

Table 24: Coagulation Diagnostics Market Forecast by Product Category

Hematology and Flow Cytometry Markets

Table 25: Hematology and Flow Cytometry Specimen Volume Forecast

Table 26: Hematology and Flow Cytometry Volume Forecast

Table 27: Hematology and Flow Cytometry Market Forecast

Table 28: Routine Hematology Volume Forecast by Test

Table 29: Flow Cytometry and Special Hematology Volume Forecast by Test

Infectious Disease Testing Market

Table 30: Infectious Disease Volume Forecast by Test

Table 31: Infectious Disease Diagnostics Market Forecast by Test

Molecular Diagnostics Market

Table 32: Molecular Diagnostic Test Volume and Sales Forecasts by Application

Table 33: Molecular Diagnostic Test Volume Forecast by Application

Table 34: Infectious Disease Volume Forecast by Test

Table 35: Molecular Diagnostics Market Forecast by Application

Table 36: Infectious Disease Diagnostics Market Forecast by Test

Contains 40 pages and 36 tables.

Read more and order at Norway Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017-2021 Future Horizons and Growth Strategies in the UK Hospital Microbiology Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Industries

The 2017-2021 Future Horizons and Growth Strategies in the UK Hospital Microbiology Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Markets.

This new report contains 886 pages, 67 tables, and presents a comprehensive opportunities in the UK hospital infectious disease testing market, including:

  • Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.
  • Current scientific views on definition, epidemiology, and etiology of major infectious diseases and microorganisms.
  • Volume and sales forecasts for 80 infectious disease tests performed in UK hospital laboratories.
  • Instrumentation technologies and feature comparison of leading analyzers.
  • Sales and market shares of leading suppliers.
  • Emerging diagnostic technologies and their potential market applications.
  • Product development opportunities.
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.
  • Business opportunities and strategic recommendations for suppliers.

Contains 886 pages and 67 tables

Read more and order at 2017-2021 Future Horizons and Growth Strategies in the UK Hospital Microbiology Testing Market: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

2017 Austria Nucleic Acid Testing (NAT) Market 2021: Supplier Strategies, Country Volume and Sales Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The 2017 Austria Nucleic Acid Testing (NAT) Market 2021: Supplier Strategies, Country Volume and Sales Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights:

  • Five-year test volume and sales forecasts
  • Feature comparison of major analyzers
  • Profiles of market players and start-up firms developing innovative technologies and products
  • Specific product and business opportunities for instrument and consumable suppliers.

Rationale:

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches.The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies.Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis:

  • Five-year test volume and sales forecasts for major applications, including:
  • Infectious Diseases
  • Forensic Testing
  • Cancer
  • Paternity Testing/HLA Typing
  • Genetic Diseases
  • Others
  • Five-year test volume and sales projections for over 30 NAT assays.

Product/Technology Review:

  • Comparison of leading molecular diagnosticanalyzers.
  • Review of molecular diagnostic technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:
  • PCR
  • bDNA
  • SDA
  • NASBA
  • TMA
  • SSSR, and others
  • LCR
  • Companies, universities and research centers developing new molecular- diagnostictechnologies and products.

Competitive Assessments:

  • Strategic profiles of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

Opportunities and Strategic Recommendations:

  • New product development opportunities with potentially significant market appeal during the next five years.
  • Alternative market penetration strategies.
  • Potential market entry barriers and risks.
  • Business planning issues and concerns.

Contains 1,120 pages and 48 tables

Read more and order at 2017 Austria Nucleic Acid Testing (NAT) Market 2021: Supplier Strategies, Country Volume and Sales Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

Brazil Clinical Chemistry Market Outlook to 2024 – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Industries

The Brazil Clinical Chemistry Market Outlook to 2024 Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Markets.

Brazil Clinical Chemistry Market Outlook to 2024

Summary

The new report, Brazil Clinical Chemistry Market Outlook to 2024, provides key market data on the Brazil Clinical Chemistry market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments – Blood Test Strips – Rapid Tests & POC, Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Electrolyte Chemistry Reagents, Enzyme Chemistry Reagents, Feces Tests – Rapid Tests & POC, Metabolite Chemistry Reagents, Substrates, Therapeutic Drug Monitoring, Urine Analysis and Urine Testing – Rapid Tests & POC.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Clinical Chemistry market segments – Blood Test Strips – Rapid Tests & POC, Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Electrolyte Chemistry Reagents, Enzyme Chemistry Reagents, Feces Tests – Rapid Tests & POC, Metabolite Chemistry Reagents, Substrates, Therapeutic Drug Monitoring, Urine Analysis and Urine Testing – Rapid Tests & POC.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the Brazil Clinical Chemistry market.
  • Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Ortho-Clinical Diagnostics Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Read more and order at Brazil Clinical Chemistry Market Outlook to 2024

Future Horizons and Growth Strategies in the European Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Industries

The Future Horizons and Growth Strategies in the European Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Markets.

This new report is a five-countrystrategic analysis of major business opportunities emerging in the clinical chemistry and immunodiagnostic markets during the next five years. The report explores future trends in major European countries (France, Germany, Italy, Spain, UK); provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.

Rationale

The clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Worldwide Market Overview

– Estimates of facilities performing clinical chemistry
and immunodiagnostic tests by country.

– Test volume and sales projections by country.

Strategic Recommendations

– New product development opportunities
with significant market appeal.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

Competitive Assessments

– Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

– The companies analyzed in the report include
Abbott, AdnaGen, Agilent, Bayer, Beckman Coulter/Danaher,
Biomedical Diagnostics, bioMerieux, Bio-Rad, DiaSorin,
Eiken, Fujirebio, Grifols, IL, Kyowa Medex, Matritech/Alere
Ortho-Clinical Diagnostics, Quest Diagnostics, Roche, Siemens, Sysmex,
Thermo Fisher, Tosoh, Wako, Wallac/PE.

Tests Analyzed in the Report:

Routine Clinical Chemistry

Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, Total,
BUN (Blood Urea Nitrogen), Calcium, Cardio CRP, Carbon Dioxide/Bicarbonate, Chloride,
Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, CRP, Ferritin, GGT, Glucose,
HDL Cholesterol, Homocysteine, Iron, LDH, LDL Cholesterol, Magnesium, Phosphorus,
Potassium, Protein, Total, Sodium, Triglycerides, Troponin, Uric Acid.

Therapeutic Drug Monitoring (TDM)

Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam,
Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus,
Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin.

Endocrine Function

Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH,
Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone,
Thyroglobulin Ab, TPO Ab, TSH.

Tumor Markers and Special Chemistry

AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid),
Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood,
PAP, PSA, Thyroglobulin, Vitamin B-12.

Immunoproteins

C3, C4, Free Light Chains, Haptoglobin, IgA, IgE Specific, IgE Total, IgG, IgM,
Immunofixation, Prealbumin, Protein Electrophoresis.

Drugs of Abuse

Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine,
LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP),
Propoxyphene, Tricyclic Antidepressants.

Geographic Coverage

– France
– Germany
– Italy
– Spain
– UK

Market Segmentation Analysis

– Comprehensive review of the market
dynamics, trends, structure, size, growth,
and key suppliers, by country.

– Test volume and sales forecasts for over 100 clinical chemistry,
TDM, endocrine, cancer, immunoprotein and abused drug assays,
by country and market segment:

° Hospitals
° Commercial/Private Laboratories
° Physician Offices/Group Practices
° Ambulatory Care Centers

Current and Emerging Products

– Analysis of current and emerging clinical chemistry
and immunodiagnostic tests.

– Review of current instrumentation technologies, and feature comparison
of high-, medium-, and low-volume/POC analyzers.

Technology Review

– Assessment of current and emerging
technologies, and their potential market applications.

– Comprehensive lists of companies developing
or marketing new technologies and products by test.

Contains 900 pages and 335 tables

Read more and order at Future Horizons and Growth Strategies in the European Clinical Chemistry and Immunodiagnostic Markets: Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Spain Histology And Cytology Market Outlook to 2024 – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Industries

The Spain Histology And Cytology Market Outlook to 2024 Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Markets.

Spain Histology And Cytology Market Outlook to 2024

Summary

The new report, Spain Histology And Cytology Market Outlook to 2024, provides key market data on the Spain Histology And Cytology market. The report provides value, in millions of US dollars within market segments – Flow Cytometers, Immunmodulators, Monoclonal Antibodies, Polyclonal Antibodies and Tissue Typing Reagents

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Histology And Cytology market segments – Flow Cytometers, Immunmodulators, Monoclonal Antibodies, Polyclonal Antibodies and Tissue Typing Reagents
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the Spain Histology And Cytology market.
  • Key players covered include Beckman Coulter Inc, Becton Dickinson and Co and Thermo Fisher Scientific Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Read more and order at Spain Histology And Cytology Market Outlook to 2024

Advances in Clinical Chemistry, Vol 81 – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Industries

The Advances in Clinical Chemistry, Vol 81 Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Markets.

Advances in Clinical Chemistry, Volume 81, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. New to this latest release are chapters that cover Microparticles in Chronic Heart Failure, Peptide Antibodies in Clinical Laboratory Diagnostics, Measurement and Clinical Utility of ßCTX in Serum and Plasma, Human Papillomavirus and its Testing Assays, Cervical Cancer Screening, and Vaccination, and Physical Exercise and DNA Injury: Good or Evil? The serial presents the latest technologies related to the field of clinical chemistry, and is the benchmark for novel analytical approaches in the clinical laboratory.

  • Provides the most up-to-date technologies in clinical chemistry and clinical laboratory science
  • Authored by world renowned clinical laboratory scientists, physicians and research scientist
  • Presents the international benchmark for novel analytical approaches in the clinical laboratory

Read more and order at Advances in Clinical Chemistry, Vol 81

2017 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Country Segment Forecasts, Emerging Technologies, Competitive Strategies – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The 2017 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Country Segment Forecasts, Emerging Technologies, Competitive Strategies Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new study 407 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.

Report Highlights

– Market shares of leading suppliers
– Business and technological trends in major markets
– Five-year test volume and sales forecasts
– Market shares of leading competitors
– Feature comparison of major analyzers
– Strategic profiles of leading market players and start-up firms developing innovative products
– Specific product and business opportunities for instrument and consumable suppliers.

Rationale

Genetic Diseases, Cancer, Forensic and Paternity molecular diagnostic testing markets are among the most rapidly growing segments of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by these markets, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Spain Market Overview

– Laboratories performing DNA sequencing and molecular diagnostic testingby country and market segment.

– Five-year test volume and sales projections.

Market Segmentation Analysis

– Five-year test volume and sales projections:

– Infectious Diseases- Forensic Testing
-Cancer- Paternity Testing/HLA Typing
– Genetic Diseases- Others- – A comprehensive analysis of the sequencing market by laboratory segment.

– Detailed market segmentation analysis, including review of the market dynamics, trends,
structure, size, growth and major suppliers.

Product/Technology Review

– Comparison of the major molecular diagnosticanalyzers.

– Extensive review of molecular diagnostic technologies, test formats, detection methodologies,
trends in testing automation and over target/signal amplification methods.

– Worldwide listings of companies, universities and research centers developing new molecular
diagnostictechnologies and products.

Competitive Assessments

– Extensive strategic assessments of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, collaborative arrangements and
new technologies/products in R&D.

– Abbott
– Affymetrix
– Agilent Technologies
– Applied Gene Technologies
– Arca Biopharma
– Beckman Coulter/Danaher
– Becton Dickinson
– Biokit
– BioMerieux
– Bio-Rad
– Biotest
– CellMark Forensics/LabCorp
– Cepheid
– Decode Genetics
– Diadexus
– Eiken
– Elitech Group
– Enzo
– Exact Sciences
– Fujirebio
– Grifols
– Hologic/Gen-Probe
– Illumina
– Kreatech/Leica
– Li-Cor Biosciences
– Monogram Biosciences
– Myriad Genetics
– Ortho-Clinical Diagnostics
– Perkin Elmer/Caliper
– Proteome Sciences
– Qiagen
– Roche
– Scienion
– Sequenom
– Shimadzu
– Siemens
– Sierra Molecular
– Takara Bio
– Tecan Group
– Thermo Fisher

– Comprehensive listings of companies developing and marketing molecular
diagnostic products, by test and application.

Opportunities and Strategic Recommendations

– Specific new product development opportunities with potentially significant market appeal
during the next five years.

– Design criteria for new products.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

– Business planning issues and concerns.

Contains 407 pages

Read more and order at 2017 Spain Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing: Country Segment Forecasts, Emerging Technologies, Competitive Strategies

Saudi Arabia Molecular Diagnostic Analyzers and Reagents Market 2021: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Industries

The Saudi Arabia Molecular Diagnostic Analyzers and Reagents Market 2021: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics, Molecular Diagnostics Markets.

This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years.

Highlights

– Five-year test volume and sales forecasts
– Feature comparison of major analyzers
– Profiles of market players and start-up firms developing innovative technologies
and products
– Specific product and business opportunities for instrument and consumable suppliers

Rationale

The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years.

Market Segmentation Analysis

– Five-year test volume and sales forecasts for major applications, including:

&nbsp&nbsp- Infectious Diseases &nbsp&nbsp- Forensic Testing
&nbsp&nbsp- Cancer&nbsp &nbsp &nbsp- Paternity Testing/HLA Typing
&nbsp&nbsp- Genetic Diseases &nbsp&nbsp- Others

– Five-year test volume and sales projections for over 30 NAT assays.

Product/Technology Review

– Comparison of leading molecular diagnosticanalyzers.

– Review of molecular diagnostic technologies, test formats, detection methodologies,
trends in testing automation and over 30 target/signal amplification methods, including:

– PCR – bDNA
– SDA – NASBA
– TMA – SSSR, and others
– LCR

– Companies, universities and research centers developing new molecular-
diagnostictechnologies and products.

Competitive Assessments

– Strategic profiles of major suppliers and emerging market entrants,
including their sales, product portfolios, marketing tactics, collaborative arrangements and
new technologies/products in R&D.

Opportunities and Strategic Recommendations

– New product development opportunities with potentially significant market appeal
during the next five years.

– Alternative market penetration strategies.

– Potential market entry barriers and risks.

– Business planning issues and concerns.

Contains 1,120 pages and 48 tables

Read more and order at Saudi Arabia Molecular Diagnostic Analyzers and Reagents Market 2021: Supplier Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

2017-2021 Germany Immunodiagnostics Market: Supplier Shares and Sales Forecasts by Test Category – Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Industries

The 2017-2021 Germany Immunodiagnostics Market: Supplier Shares and Sales Forecasts by Test Category Report has been published. It provides updated in 2018 year analysis of industries from Diagnostics, Healthcare, Healthcare Services, In Vitro Diagnostics Markets.

This report provides an overview of the German immunodiagnostics market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays.

This report includes the following tables@

  • Clinical Chemistry and Immunodiagnostic Volume Forecasts By Test Category
  • Clinical Chemistry and Immunodiagnostic  Reagent Sales Forecasts By Test Category
  • Clinical Chemistry and Immunodiagnostic Instrument Sales Forecasts By Analyzer Type
  • Estimated Sales and Market Shares of Major Suppliers  Of Clinical Chemistry Instruments and Reagents
  • Estimated Sales and Major Shares of Major Suppliers  Of Immunodiagnostic Instruments and Reagents

Contains 21 pages and 5 tables

Read more and order at 2017-2021 Germany Immunodiagnostics Market: Supplier Shares and Sales Forecasts by Test Category